Investing Profile

Robert Tepper

InvestorVC
Partner at Third Rock Ventures
Photo of Robert Tepper, Partner at Third Rock Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
17
$770M
CompanyStageDateRound SizeTotal Raised
Casma Therapeutics
Series CNov 2022$46M
$160M
Co-investors: Cary Pfeffer (Third Rock Ventures), Hiromichi Kimura (Astellas Venture Management), Millie Ray (The Column Group)
Constellation Pharmaceuticals
Series FApr 2018$100M
Series EDec 2015$55M
Series BJun 2011$15M
Series BJun 2010$22M
Series AAug 2009$17M
Series AApr 2008$32M
$390M
Co-investors: Brian Gallagher (Abingworth), Tony Evnin (Venrock), David Goeddel (The Column Group)
Allena Pharmaceuticals
Series BDec 2014$25M
Series ANov 2011$15M
$93M
Co-investors: Steve Kraus (Bessemer Venture Partners), James N. Topper (Frazier Healthcare Partners)
Kala Pharmaceuticals
Series BApr 2014$23M
Series AFeb 2013$12M
Private EquityMar 2012$7M
$110M
Co-investors: Kevin Bitterman (Atlas Venture), Karen Wagner (Ysios Capital)
Alcresta
Series BJul 2013$10M
Series AApr 2012$10M
$69M
Co-investors: Steve Kraus (Bessemer Venture Partners), James N. Topper (Frazier Healthcare Partners)
Bluebird Bio
Series DJul 2012$60M
Series CApr 2011$30M
Series BMar 2010$35M
$130M
Co-investors: Geert-Jan Mulder (Forbion), Philip Reilly (Third Rock Ventures), Steven Gillis (ARCH Venture Partners)